跳至主要内容
临床试验/NCT03535987
NCT03535987已完成不适用

Pilot Cohort Study of Rb-82 Myocardial PET Imaging to Evaluate Coronary Microvascular Dysfunction in Men With Prostate Cancer Receiving Androgen-Deprivation Therapy

Abramson Cancer Center at Penn Medicine1 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2018年1月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
18
试验地点
1
主要终点
number of subjects who successfully complete Rb-82 myocardial PET Imaging assessments

研究概览

简要总结

To determine the feasibility of using myocardial PET imaging as a means to assess cardiovascular risk in men with prostate cancer planned for androgen- deprivation therapy with external beam radiation therapy.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
51 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Either clinically localized prostate cancer or biochemically-recurrent prostate cancer patients who are planned for at least 6 months ADT with a GnRH agonist and curative-intent radiation therapy per their oncologic providers.
  • Over 50 years of age. Calculated 10-year Framingham General Cardiovascular Risk Score of ≥10% at the time of planned initiation of ADT.
  • Patients must be able to read and understand English.
  • Participants must sign the informed consent form.

排除标准

  • Prior treatment with GnRH agonist therapy.
  • History of active asthma or other reactive airway disease.
  • Ischemic cardiac event (myocardial infarction, unstable angina) within the preceding 6 months.

结局指标

主要结局

number of subjects who successfully complete Rb-82 myocardial PET Imaging assessments

时间窗: 12-18 months

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验